313 related articles for article (PubMed ID: 16777946)
1. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.
Sirenko SG; Potter JD; Knollmann BC
J Physiol; 2006 Aug; 575(Pt 1):201-13. PubMed ID: 16777946
[TBL] [Abstract][Full Text] [Related]
2. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
3. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy.
Knollmann BC; Blatt SA; Horton K; de Freitas F; Miller T; Bell M; Housmans PR; Weissman NJ; Morad M; Potter JD
J Biol Chem; 2001 Mar; 276(13):10039-48. PubMed ID: 11113119
[TBL] [Abstract][Full Text] [Related]
4. Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations.
Gilda JE; Lai X; Witzmann FA; Gomes AV
Mol Cell Proteomics; 2016 Jun; 15(6):1962-81. PubMed ID: 27022107
[TBL] [Abstract][Full Text] [Related]
5. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
[TBL] [Abstract][Full Text] [Related]
8. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic troponin T mutants with opposing effects on myofilament Ca
Dieseldorff Jones KM; Koh Y; Weller RS; Turna RS; Ahmad F; Huke S; Knollmann BC; Pinto JR; Hwang HS
Arch Biochem Biophys; 2019 Jan; 661():125-131. PubMed ID: 30445044
[TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.
Montgomery DE; Tardiff JC; Chandra M
J Physiol; 2001 Oct; 536(Pt 2):583-92. PubMed ID: 11600691
[TBL] [Abstract][Full Text] [Related]
11. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
Jagatheesan G; Rajan S; Petrashevskaya N; Schwartz A; Boivin G; Arteaga GM; Solaro RJ; Liggett SB; Wieczorek DF
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H949-58. PubMed ID: 17416600
[TBL] [Abstract][Full Text] [Related]
12. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
Szczesna D; Zhang R; Zhao J; Jones M; Guzman G; Potter JD
J Biol Chem; 2000 Jan; 275(1):624-30. PubMed ID: 10617660
[TBL] [Abstract][Full Text] [Related]
13. Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.
Baudenbacher F; Schober T; Pinto JR; Sidorov VY; Hilliard F; Solaro RJ; Potter JD; Knollmann BC
J Clin Invest; 2008 Dec; 118(12):3893-903. PubMed ID: 19033660
[TBL] [Abstract][Full Text] [Related]
14. Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium.
Ventura C; Miller R; Wolf HP; Beier N; Jonas R; Klockow M; Lues I; Hano O; Spurgeon HA; Lakatta EG
Circ Res; 1992 Jun; 70(6):1081-90. PubMed ID: 1533576
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
16. Myosin cross-bridges do not form precise rigor bonds in hypertrophic heart muscle carrying troponin T mutations.
Midde K; Dumka V; Pinto JR; Muthu P; Marandos P; Gryczynski I; Gryczynski Z; Potter JD; Borejdo J
J Mol Cell Cardiol; 2011 Sep; 51(3):409-18. PubMed ID: 21683708
[TBL] [Abstract][Full Text] [Related]
17. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.
Schober T; Huke S; Venkataraman R; Gryshchenko O; Kryshtal D; Hwang HS; Baudenbacher FJ; Knollmann BC
Circ Res; 2012 Jul; 111(2):170-9. PubMed ID: 22647877
[TBL] [Abstract][Full Text] [Related]
18. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I.
Layland J; Cave AC; Warren C; Grieve DJ; Sparks E; Kentish JC; Solaro RJ; Shah AM
FASEB J; 2005 Jul; 19(9):1137-9. PubMed ID: 15855227
[TBL] [Abstract][Full Text] [Related]
19. Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.
Huke S; Venkataraman R; Faggioni M; Bennuri S; Hwang HS; Baudenbacher F; Knollmann BC
Circ Res; 2013 May; 112(10):1334-44. PubMed ID: 23532597
[TBL] [Abstract][Full Text] [Related]
20. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
